MedTrace Logo

Biomarker in Lung Diseases

NCT00989846 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2009-10-14

No results posted yet for this study

Summary

Disease related biomarkers have been established decades ago, e.g. blood glucose for diabetes diagnosis and management. Their discovery has grown dramatically during the past decade and they have the potential to lead the physician in diagnosis -especially differential diagnosis - and therapy.

However, a specific serum-biomarker in lung diseases has not been established. Aim of the current study is to to measure lung specific proteins in the serum in patients with various lung diseases and to correlate those with disease severity, lung function and other laboratory results

Conditions

  • Lung Diseases

Interventions

OTHER

biomarker

measuring serum-biomarkers

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Michael Kreuter, MD · Thoraxklinik Heidelberg, Germany

  • Felix JF Herth, MD · Thoraxklinik Heidelberg Germany

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-03-31
Completion
2010-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00989846 on ClinicalTrials.gov